November 18, 2015
Advanced Oncotherapy disposes of its subsiadiary for £100K
Advanced Oncotherapy has disposed of its subsidiary, Oncotherapy Resources Ltd (ORL), for a total cash consideration of £100,000 to Xstrahl.…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: ORL